ArticleCell reports. Medicine2024

Targeting NAT10 inhibits osteosarcoma progression via ATF4/ASNS-mediated asparagine biosynthesis.

Yutong Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.